Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

Clinical trial NCT05852730 · RECRUITING

Trial details

NCT number: NCT05852730
Sponsor: Repurposed Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Motion Sickness, Space Motion Simulation Parabolic Flight

Start date: 2021-08-10
Primary completion: 2026-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.